Dr. Abdulraziaq Al-Madani Diabetes Complications in the Gulf Countries.

Slides:



Advertisements
Similar presentations
UPDATE ON DIABETES AND INSULIN THERAPY BY Dr. M. SYED SULAIMAN. M
Advertisements

Egyptian Perspective On Prediabetes & Diabetes
The Burden of Obesity in North Carolina Obesity-Related Chronic Disease.
بسم الله الرحمن الرحيم. Immunological markers in the pathogenesis of type 1 diabetes in Saudi children.
Cardiovascular Diseases Nejoud Al Mana 6B. Introduction The issue I am studying is Age standardized mortality rate for cardiovascular diseases, I compared.
The Socio-economic Burden of Diabetes in Developing Countries Lessons from studies in Egypt Professor Morsi Arab Egypt.
Glucose Tolerance Test Diabetes Mellitus Dr. David Gee FCSN Nutrition Assessment Laboratory.
Prevalence of smoking in Saudi Arabia Yousef Abdullah Al Turki MBBS,DPHC,ABFM Associate Professor Family Medicine College of Medicine King Saud University.
Diabetes: The Numbers Michigan Diabetes Partners in Action and Michigan Department of Community Health Diabetes: The Numbers Adapted from the National.
DIABETES MELLITUS TYPE II NON INSULIN DEPENDENT DIABETES (NIDDM)
Al-Fada AA & Bin Abdulrahman KA, King Saud University, Riyadh, Saudi Arabia Assessment of Care for Type 2 Diabetic Patients at the PHC Clinics of a Referral.
Diabetes Mellitus Type 2
Diabetes Mellitus: General information CDC 14.7 million Americans diagnosed (2004) Est. 5 million not diagnoses.
Action and forces influence nutrition through life cycle (nutrition intervention) Maternity and Infancy Dr. Dina Qahwaji.
What is Diabetes? Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively.
RCS 6080 Medical and Psychosocial Aspects of Rehabilitation Counseling Diabetes and PVD.
1 Prediabetes Burden. 2 Epidemiology: Health Performance Gaps Prevalence Risk factors –Metabolic syndrome –Obesity Clinical risks of prediabetes –Progression.
Prediabetes Burden.
FACTS At least 194 m people worldwide suffer from diabetes; this figure is likely to be more than double by 2030 At least 194 m people worldwide suffer.
Epidemiology of Diabetes mellitus
Diabetes Mellitus Ibrahim Sales, Pharm.D. Assistant Professor of Clinical Pharmacy King Saud University
Arab Gulf States Six States- Saudi Arabia, Kuwait, Bahrain, Qatar, UAE & Oman.
The Global Burden of Diabetes Dr. Naeem Zahid MD, PhD, MBA.
Diabetes Mellitus as a health problem in Sri Lanka
Epidemiology of Diabetes Mellitus by Santi Martini Departemen of Epidemiology Faculty of Public Health University of Airlangga.
Health Disparities of Minority Women and Diabetes Kathleen M. Rayman, Ph.D., RN Appalachian Center for Translational Research in Disparities Faculty Development.
Pattern of Diabetes Emergencies among adult Yemeni Diabetic Patients Dr. Zayed Atef Faculty of Medicine Sana’a University.
Epidemiology of Diabetes mellitus Ashry Gad Mohamed, Hafsa Raheel Department of Family & Community Medicine KSU.
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients in Thailand Dr. Mya Thandar Dr.PH. Batch 5 1.
Epidemiology of Diabetes mellitus
Diabetes in Europe By: Vincent Isby Brandy Jones Deion Robinson Darien Dufachard.
Ashry Gad Mohamed Prof. of Epidemiology KSU October 16,
IDC 1.1 Global and National Burden of Diabetes Diabetes Mellitus: classification New (WHO) Screening and Diagnostic Criteria –Diabetes, Impaired Glucose.
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients Dr. Mya Thandar.
Diabetes as a Global Health Problem The IDF meets the Challenge By Prof. Morsi Arab IDF Chairman MENA Region Prof. Morsi Arab IDF Chairman MENA Region.
The ADVANCE trial: update and new results Jean-François Gautier Saint Louis Hospital, Paris 12 th Meeting of the Mediterranean Group for the Study of Diabetes.
Arab Gulf States Six States- Saudi Arabia, Kuwait, Bahrain, Qatar, UAE & Oman.
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients in Thailand Dr. Mya Thandar DrPH Batch 5 1.
Diabetes mellitus “ Basic approach” Dr Sajith.V.S MBBS,MD (Gen Med )
Prevalence of Poor Glycemic Control and Depression Among Diabetic Adolescent Youth Presented By: Atwater K and Wilson S Prairie View A & M University Prevalence.
American Diabetes Association National Capital Area and Lions District 24-A Team up to Stop Diabetes® and Blindness With an LCIF Core 4 Diabetes Grant.
Diabetes. Diabetes mellitus, or simply diabetes, is a group of metabolic diseases in which a person has high blood sugar, either because the body does.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015
Double Jeopardy. International Diabetes Federation Diabetes State of raised blood glucose (hyperglycaemia) associated with premature mortality Pancreas.
Epidemiology of Diabetes in Hispanic Americans. Prevalence of Abnormal Glucose Tolerance in Three Ethnic Groups.
TOP 10 Number of people with diabetes (20-79 years), 2010 and 2030.
Retinopathy in Youth With Type 2 Diabetes Participating in the TODAY Clinical Trial Featured Article: TODAY Study Group* Diabetes Care Volume 36:
Impact of Diabetes on Cardiovascular Risk C.Richard Conti M.D. MACC Oct 16,2004 GWICC Beijing, PRC.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015
Burj Khalifa in Dubai higher than the Twin Towers in Malaysia (V) Burj Khalifa in Dubai is higher than the Twin Towers in Malaysia.
Source: WHO Global Burden of Disease Report Update 2004, Geneva 2008 Global Burden of Disease: chronic NCD responsible for high rates of premature mortality.
Part 3. Diabetes Report Card: HbA 1c Levels in the United States Hoerger TJ, et al. Diabetes Care. 2008;31: Patients (%) HbA 1c (%)
An American Epidemic. Age-adjusted Percentage of U.S. Adults Who Were Obese or Who Had Diagnosed Diabetes Obesity (BMI ≥30 kg/m 2 ) Diabetes
Dr. Nadira Mehriban. INTRODUCTION Diabetic retinopathy (DR) is one of the major micro vascular complications of diabetes and most significant cause of.
Epidemiology of Diabetes Mellitus. Diabetes mellitus is a group of diseases marked by high levels of blood glucose resulting from defects in insulin production,
Circulation. 2014;129: Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy.
Cardiovascular Risk: A global perspective
First-year death rates by modality figure 8
Epidemiology of Diabetes mellitus Noura A. Abouammoh KSU
IDF DIABETES ATLAS Eighth edition 2017.
Macrovascular Complications Microvascular Complications
Incidence of CV Events in Subjects With T2D vs the Nondiabetic CAD Population
FACTS At least 194 m people worldwide suffer from diabetes; this figure is likely to be more than double by 2030 Around 4 m deaths every year are related.
Prediabetes Burden.
Healthcare Policies in GCC: Challenges and Future Directions:
Incidence of CV Events in Subjects With T2D vs the Nondiabetic CAD Population
The Clock is ticking for the world’s leaders
Lorna Perez, Ethan Gough
IDF DIABETES ATLAS Eighth edition 2017.
Prevalence of nephropathy, retinopathy, and neuropathy in subjects achieving all (A) three targets, (B) two targets, (C) one target, and (D) none, and.
Presentation transcript:

Dr. Abdulraziaq Al-Madani Diabetes Complications in the Gulf Countries

Diabetes Mellitus an Epidemic Disease in the Gulf Countries Epidemiological Data Diabetes Mellitus Prevalence Kuwait 14.8 Bahrain 11.0 UAE 15.7 Qatar 15.0 Saudi Arabia 12.3 Oman 10.0

Diabetes Mellitus an Epidemic Disease in the Gulf Countries Epidemiological Data Impaired Glucose Tolerance Prevalence Kuwait 12.8 Bahrain 11.0 UAE 13.2 Qatar 11.0 Saudi Arabia 11.9 Oman 10.0

Prevalence of Diabetes Mellitus Prevalence: Diabetes prevalence in the adult population (>20 years) by year and region for developed and developing countries and world total. WHO report Diabetes Complications in the Gulf Countries

Number of diabetics Number of Diabetics: WHO data for the expected number of diabetic patients according to regions and years. WHO report Millions Diabetes Complications in the Gulf Countries

Diabetic Neuropathy Diabetic Retinopathy Diabetic Nephropathy Diabetic Vasculopathy

Nephropathy Prevalence of microvascular complications: Comparing data from Arab countries with data of the highest & lowest prevalence world wide in the year The major complications will be soon the highest in Arab countries due to the lack of prevention programs. WHO report Neuropathy Retinopathy Diabetes Complications in the Gulf Countries

Diabetic Neuropathy Diabetic Retinopathy Diabetic Nephropathy Diabetic Vasculopathy

Neuropathy Neuropathy: Number of persons with diabetic neuropathy in different countries and according to the time. WHO report 2000 Diabetes Complications in the Gulf Countries

NEUROPATHY WITH DURATION % Years Diabetes Care 1, IDDM NIDDM

Diabetes Complications in the Gulf Countries IDDMNIDDMTotal Population: No %10%90%( 14% ) Duration: 10 years ( % )10%30% ( Number) years ( % )30%80% ( Number) years ( % )60%100% ( Number ) Number of Neuropathic Saudi Diabetics

Diabetes Complications in the Gulf Countries Diabetic Neuropathy Diabetic Retinopathy Diabetic Nephropathy Diabetic Vasculopathy

Diabetes Complications in the Gulf Countries RETINOPATHY WITH DURATION % Years ADA 1993 Vital Statistic Any Retinopathy Proliferative Retinopathy

Diabetes Complications in the Gulf Countries BLINDNESS BY DURATION OF DIABETES % Years ADA 1993 Vital Statistic Age at diagnosis 20 years old Age at diagnosis 60 years old

Retinopathy Retinopathy: Number of persons with diabetic retinopathy in different countries and according to the time. WHO report 2000 Diabetes Complications in the Gulf Countries

Prevalence of Retinopathy in Saudi diabetic patients 31.5% IDDM42.5% NIDDM25.3% Risk factors for Retinopathy in Saudi diabetic patients  Duration > 10 years.  Presence of nephropathy.  Older than 60 years.  Poor diabetes control.  Use of insulin. Diabetes Complications in the Gulf Countries

Diabetic Neuropathy Diabetic Retinopathy Diabetic Nephropathy Diabetic Vasculopathy

Diabetes Complications in the Gulf Countries NEPHROPATHY WITH DURATION % Years NIDDM IDDM NovoCare 1995 Years N Engl J Med 1987, Rate/ 100 subjects/ year

Nephropathy Nephropathy: Number of persons with diabetic nephropathy in different countries and according to the time. WHO report 2000 Diabetes Complications in the Gulf Countries

ESRF in Saudi Arabia: Increase in the total cases. More increase in the diabetic ESRF. Slow transplantation program. % Diabetes Complications in the Gulf Countries

Dialysis in Riyadh Number of patients. Vs Number of units. Diabetes Complications in the Gulf Countries

Diabetic Neuropathy Diabetic Retinopathy Diabetic Nephropathy Diabetic Vasculopathy

2000 Saudi diabetics ( Initial ) General Mortality in Saudi diabetic patients 2000 Diabetics attending Diabetic Center KSU. 70 % Diabetes Complications in the Gulf Countries

General mortality55 per 1000 per 5yrs 11 per 1000 per year Cardiac mortality8 per 1000 per year Cardiac Mortality70% Non-cardiac Mortality30% Cardiac Morbidity9.1% Cardiac Mortality in Saudi diabetic patients 2000 Saudi diabetics ( Initial ) Cardiac mortality8 per 1000 per year In Saudi Arabia12,000,000 Inhabitance 1,500,000 Diabetics Cardiac deaths in diabetics =8 X 1,500 = 12,000 per year Cardiac mortality8 per 1000 per year In Saudi Arabia12,000,000 Inhabitance 1,500,000 Diabetics Cardiac deaths in diabetics =8 X 1,500 = 12,000 per year Diabetes Complications in the Gulf Countries

Number of deaths: In millions for patients aged > 20 years estimated for the year Percentage of total deaths attributable to diabetes: 11.9%Baseline 3.5%Optimistic 3.8%Etiologic ~ 9%WHO WHO report % Number of death Diabetes Complications in the Gulf Countries

Diabetes in the Gulf countries Diabetes is the leading cause forBlindness Diabetes is the leading cause forESRF Diabetes is the leading cause forIHD Diabetes is the leading cause forCVA Diabetes is the leading cause forAmputation Diabetes Complications in the Gulf Countries